Top Markets
Coin of the day
20/20 Biolabs Inc. 20/20 Biolabs Inc.

20/20 Biolabs Inc.

AIDX
Classifica tra le azioni #33864
20/20 GeneSystems, Inc. operates as a clinical laboratory testing company... 20/20 GeneSystems, Inc. operates as a clinical laboratory testing company focused on cancer screening and viral testing services. The company provides multi-cancer early detection blood testing, including a test called OneTest, and offers viral testing services such as rapid COVID-19 test kits, including the Assure COVID-19 IgG/IgM rapid test. It operates the Clinical Lab Innovation Axcelerator (CLIAx), a shared laboratory facility that supports diagnostic test developers in bringing products to the U.S. market. The company also delivers its cancer screening algorithm technology through a software as a service (SaaS) platform in partnership with healthcare providers and supports diagnostic startups by offering access to shared laboratory space and resources. The company was founded in 2000 and is based in Gaithersburg, Maryland.
Prezzo delle azioni
$0.5475
Ultima sincronizzazione: 2026-08-14
Capitalizzazione di mercato
$6.71M
Variazione (1 giorno)
5.57%
Variazione (1 anno)
-
Paese
US
Scambia 20/20 Biolabs Inc. (AIDX)

Categoria

Cronologia dei frazionamenti azionari per 20/20 Biolabs Inc. (AIDX)
L’azione 20/20 Biolabs Inc. (simbolo: AIDX) ha subito un totale di 0 frazionamenti.
L’ultimo frazionamento è avvenuto il Aug 17, 2026.
Una quota di AIDX acquistata prima di Aug 17, 2026 equivale oggi a 0 quote di AIDX.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
Non abbastanza dati per le date fornite.
Frazionamenti azionari di aziende simili o concorrenti